Voyager Therapeutics, Inc.

VYGR · XNAS

CIK 1640266fmd_12B25K46MQ2B3ZPNGZ61HGCBAMManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).